Rani Therapeutics Holdings Inc expected to post a loss of 26 cents a share - Earnings Preview

Rani Therapeutics Holdings

14/11/2024 03:50

* Rani Therapeutics Holdings Inc  RANI.OQ   RANI.O  is
expected
to show no change in quarterly revenue when it reports 
results on November 15 (estimated) for the period ending
September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Rani Therapeutics
Holdings Inc
is for a loss of 26 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Rani
Therapeutics
Holdings Inc is $11.00​, above​ its last closing price of $2.47.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.33       -0.32      -0.26     Beat    17.6
 Mar. 31 2024  -0.21       -0.20      -0.29     Missed  -42.6
 Dec. 31 2023  -0.32       -0.31      -0.27     Beat    13.4​
 Jan. 1 0001   -0.38       -0.37      -0.36     Beat    1.6
 ​​Jun.        -0.35       -0.40      -0.37     Beat    8.5
 30 2023                                                
 Mar. 31 2023  -0.39       -0.41      -0.33     Beat    20.2​
 Dec. 31 2022  -0.36       -0.35      -0.35     Met     -0.6
 Jan. 1 0001   -0.46       -0.47      -0.33     Beat    29.5
 This summary was machine generated November 14 at 03:50 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)